University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Acceptance and Compassion to Enhance Self-care Pilot

Not Applicable

Completed

Conditions: HIV/AIDS
Substance Use Disorder

Interventions: Behavioral: ACES Pilot

First Posted Date: 2015-08-28

Last Posted Date: 2020-06-19

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 10

Registration Number: NCT02535455

Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant

Phase 4

Completed

Conditions: HIV
Hepatitis C
Cirrhosis

Interventions: Drug: Harvoni

First Posted Date: 2015-08-27

Last Posted Date: 2021-02-02

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 68

Registration Number: NCT02533934

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
🇺🇸
Mt. Sinai Medical Center, New York, New York, United States

and more 5 locations

Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study

Phase 1

Terminated

Conditions: HIV
Human Immunodeficiency Virus

Interventions: Drug: Euphorbia kansui extract powder prepared as tea

First Posted Date: 2015-08-24

Last Posted Date: 2024-04-19

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 5

Registration Number: NCT02531295

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Trial of a Best-Practice Alert in the Electronic Medical Record to Reduce Unnecessary Telemetry Monitoring

Not Applicable

Completed

Conditions: Arrhythmia

Interventions: Behavioral: Best-practice alert

First Posted Date: 2015-08-20

Last Posted Date: 2019-11-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1021

Registration Number: NCT02529176

Deceased Organ Donor Interventions to Protect Kidney Graft Function

Not Applicable

Completed

Conditions: Organ Donation
Organ Transplant Failure or Rejection
Delayed Graft Function
Brain Death

Interventions: Other: Pump Eligible - Normothermia - Pump Both Kidneys
Other: Not Pump Eligible - Hypothermia
Other: Not Pump Eligible - Normothermia
Other: Pump Eligible - Hypothermia and Pump Right Kidney
Other: Pump Eligible - Hypothermia and Pump Left Kidney

First Posted Date: 2015-08-17

Last Posted Date: 2022-06-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1427

Registration Number: NCT02525510

Locations: 🇺🇸
Southwest Transplant Alliance, Dallas, Texas, United States
🇺🇸
LifeGift, Houston, Texas, United States
🇺🇸
Donor Alliance, Denver, Colorado, United States

and more 4 locations

Use of CXCL9 as a Biomarker of Acthar Efficacy

Phase 4

Recruiting

Conditions: Sarcoidosis

Interventions: Drug: Acthar gel

First Posted Date: 2015-08-14

Last Posted Date: 2023-05-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 14

Registration Number: NCT02523092

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Bococizumab HIV Evaluation (B-HIVE) Study

Phase 3

Terminated

Conditions: Cardiovascular Disease
Dyslipidemia

Interventions: Drug: Placebo
Drug: Bococizumab

First Posted Date: 2015-08-14

Last Posted Date: 2019-06-19

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 11

Registration Number: NCT02524106

Locations: 🇺🇸
San Francisco General Hospital, San Francisco, California, United States
🇺🇸
San Francisco Veteran's Affair Medical Center, San Francisco, California, United States
🇺🇸
Quest Clinical Research, San Francisco, California, United States

Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

Phase 2

Recruiting

Conditions: Optic Neuritis

Interventions: Drug: Placebo
Drug: Clemastine

First Posted Date: 2015-08-13

Last Posted Date: 2024-07-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 90

Registration Number: NCT02521311

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

Cigarette Reduction Using the Quitbit Digital Lighter and Mobile Application for Smoking Cessation: a Randomized Controlled Trial

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: Gradual Cessation w/ Quitbit
Behavioral: Gradual Cessation

First Posted Date: 2015-08-04

Last Posted Date: 2020-01-13

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 124

Registration Number: NCT02515500

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer

Phase 2

Terminated

Conditions: Prostatic Neoplasms
Pelvic Nodal

Interventions: Drug: Enzalutamide
Drug: Leuprolide
Radiation: Intensity-Modulated Radiation Therapy

First Posted Date: 2015-07-27

Last Posted Date: 2021-10-12

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 11

Registration Number: NCT02508636

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy